HM Payson & Co’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9
Closed -$462 1056
2024
Q3
$462 Buy
+9
New +$603 ﹤0.01% 1071
2023
Q4
Sell
-1
Closed -$81 982
2023
Q3
$81 Sell
1
-141
-99% -$11.1K ﹤0.01% 993
2023
Q2
$11.5K Hold
142
﹤0.01% 789
2023
Q1
$17.3K Hold
142
﹤0.01% 739
2022
Q4
$18.9K Hold
142
﹤0.01% 681
2022
Q3
$16K Hold
142
﹤0.01% 726
2022
Q2
$19K Hold
142
﹤0.01% 723
2022
Q1
$24K Hold
142
﹤0.01% 714
2021
Q4
$25K Buy
142
+127
+847% +$22.7K ﹤0.01% 726
2021
Q3
$3K Hold
15
﹤0.01% 941
2021
Q2
$2K Hold
15
﹤0.01% 986
2021
Q1
$2K Hold
15
﹤0.01% 1033
2020
Q4
$1K Buy
+15
New +$1.5K ﹤0.01% 1043

Other funds holding CNXC

HM Payson & Co's CNXC Position: Q4 2024 in Review

HM Payson & Co sold out of Concentrix (CNXC) in Q4 2024, closing a stake of 9 shares — an estimated $462 sold.

HM Payson & Co first reported a position in CNXC in Q4 2020 and held it in 13 quarters. The position peaked at $25K in Q4 2021. 291 funds tracked by Wall St. Rank hold CNXC as of Q4 2024.

  • HM Payson & Co reported no remaining Concentrix position as of Q4 2024 after selling out during the quarter.
  • HM Payson & Co sold 9 Concentrix shares in Q4 2024, an estimated $462.
  • HM Payson & Co first reported a position in Concentrix in Q4 2020 and held it in 13 quarters.
  • HM Payson & Co's Concentrix position peaked at $25K in Q4 2021.
  • 291 funds tracked by Wall St. Rank held Concentrix as of Q4 2024.

Based on HM Payson & Co's 13F filing for Q4 2024, filed 7 Feb 2025.